Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Applied DNA Sciences, Inc.

APDNNASDAQ
Healthcare
Medical - Diagnostics & Research
$5.62
$1.35(31.62%)
U.S. Market opens in 15h 30m

Applied DNA Sciences, Inc. (APDN) Stock Overview

Explore Applied DNA Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap7.3M
P/E Ratio-0.59
EPS (TTM)$-57.12
ROE-8.97%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

APDN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Applied DNA Sciences, Inc. (APDN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 10.42, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.59 and a market capitalization of 7.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
53.13%
1-Month Change
31.62%
3-Month Change
23.52%
6-Month Change
-57.81%
Year-to-Date (YTD) Change
-96.97%
1-Year Change
-95.98%
3-Year Change
-99.98%
5-Year Change
-99.99%
All-Time (Max) Change
-100.00%

Contact Information

631 840 8800
50 Health Sciences Drive, Stony Brook, NY, 11790

Company Facts

460 Employees
IPO DateJul 15, 2003
CountryUS

Frequently Asked Questions